Michael H. Rosenthal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michael H. Rosenthal has a total of 302 co-authors. Here are the top co-authors by number of shared publications:
- Lauren K. Brais
Dana-Farber Cancer Institute, Boston, MA
128 shared publications - Douglas A. Rubinson
Dana-Farber Cancer Institute 1 , Boston, Massachusetts
124 shared publications - Andrew J. Aguirre
Dana-Farber Cancer Institute 1 , Boston, Massachusetts
123 shared publications - Brian M. Wolpin
Dana-Farber Cancer Institute, Boston, MA
123 shared publications - Kevin S. Kapner
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA
123 shared publications - Kimmie Ng
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA
123 shared publications
Latest Publications
- 10 August 2026
- Published by Springer Nature in Abdominal Radiology
- p. 1-17
Imaging and management of biliary complications after biliary interventions
- 10 August 2026
- Published by Springer Nature in Abdominal Radiology
- p. 1-17
Imaging and management of biliary complications after biliary interventions
- Open Access
- 19 January 2026
- Published by Wiley in Clinical and Translational Medicine
- Vol. 16 (1) , e70573
Plasma cell‐free DNA markers predict occult metastases in patients with resectable pancreatic ductal adenocarcinoma
- 19 January 2026
- Published by Wiley in Clinical and Translational Medicine
- Vol. 16 (1) , e70573
Open AccessPlasma cell‐free DNA markers predict occult metastases in patients with resectable pancreatic ductal adenocarcinoma
- 20 June 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (1) , 104-117
Biliary tract neoplasms from common to rare: diagnosis, assessment, and management
Biliary tract neoplasms include a diverse set of benign and malignant entities that share both clinical presentations and imaging features. Radiologists need to understand the diagnostic features of these neoplasms to recognize them at initial diagnosis, and we must also provide key information to our surgical and oncology colleagues to facilitate proper management. This work reviews the most important intrahepatic and extrahepatic biliary neoplasms with an emphasis on radiological findings and differentiating features. This work also reviews normal anatomy and key variants of the biliary tree, arterial supply, and venous drainage that impact treatment planning for these entities. Assessment of tumor extent, involvement of critical anatomy, and differential diagnoses are also discussed. This work will support readers in their understanding of biliary tract neoplasms and in the delivery of actionable radiology reports as part of an integrated multidisciplinary care team.
- 20 June 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (1) , 104-117
Biliary tract neoplasms from common to rare: diagnosis, assessment, and management
Biliary tract neoplasms include a diverse set of benign and malignant entities that share both clinical presentations and imaging features. Radiologists need to understand the diagnostic features of these neoplasms to recognize them at initial diagnosis, and we must also provide key information to our surgical and oncology colleagues to facilitate proper management. This work reviews the most important intrahepatic and extrahepatic biliary neoplasms with an emphasis on radiological findings and differentiating features. This work also reviews normal anatomy and key variants of the biliary tree, arterial supply, and venous drainage that impact treatment planning for these entities. Assessment of tumor extent, involvement of critical anatomy, and differential diagnoses are also discussed. This work will support readers in their understanding of biliary tract neoplasms and in the delivery of actionable radiology reports as part of an integrated multidisciplinary care team.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer
TP53 hotspot variant distribution
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer
TP53 hotspot variant distribution
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S10 from Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer
BRAF alteration clonality assessment
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S10 from Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer
BRAF alteration clonality assessment
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S14 from Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer
MAPK pathway gene VUS analysis for oncogenicity in KRAS WT, MAPK Neg
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S14 from Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer
MAPK pathway gene VUS analysis for oncogenicity in KRAS WT, MAPK Neg
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S16 from Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer
Mutational Profile of BRAF in frame deleted organoid cases
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S16 from Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer
Mutational Profile of BRAF in frame deleted organoid cases
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S11 from Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S11 from Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer
TP53 hotspot variant distribution
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer
TP53 hotspot variant distribution